CCRM Australia
CCRM Australia is the Australian Hub of the highly successful Centre for Commercialization of Regenerative Medicine in Canada (CCRM). Established as a not-for-profit with a national focus, CCRM Australia’s mission is to address bottlenecks in the translation and commercialization of regenerative medicine discoveries in Australia, many of which have the potential to cure some of the most devastating and costly diseases in the world today. CCRM Australia’s commercially focused solutions enable businesses and research partners to achieve their commercialization objectives by providing customized country, market and industry-specific support. To date, CCRM Australia has collaborated with researchers to advance their regenerative medicine technologies, evaluated and supported promising technologies to seek investment funding, facilitated commercialization training and worked with international biotechnology companies to set up their clinical trials in Australia. CCRM Australia continues to do so, while providing access to resources and expertise from other CCRM Hubs around the world.
Posts by: CCRM Australia
Learnings from First Nations’ traditional medicine could enhance the effectiveness of regenerative medicine
This blog post was written by Jimmy Yu (see LinkedIn page) with supervision by Dr. Chih Wei Teng. Traditional medicine and the practices of Australia’s First Nations – Australian Aboriginal people and Torres Strait Islander – embody a world imbued with ancient wisdom, intricate rituals, and spiritual beliefs that have long eluded the grasp of […]
Biotechnology sectors are shaped by different government approaches to investment
This blog post was written by Jimmy Yu (see LinkedIn page) with supervision by Dr. Chih Wei Teng. Countries that responded better during the COVID-19 pandemic showed good, coordinated efforts between different government agencies and departments. Known as the “whole-of-government approach,” this model would help Australia become more self-sustainable in research, manufacturing and commercializing medicine […]
Having the right country alliances is key for internationalization efforts: South Korea
Bhavi Kadakia was an intern with CCRM Australia in 2020 and is currently employed at Novotech. In the health-care sector, translation and commercialization have traditionally been described as complex and requiring heavy investment. As such, it is imperative for biotechnology companies to make the best use of their money and maximize the time to market, […]
CCRM Australia: Lessons from the front line of commercialization
Silvio Tiziani, MBA, GAICD, is the CEO of CCRM Australia, leading efforts to bridge the gap between research and industry in regenerative medicine. With extensive experience across academia, health, and industry, he has successfully developed strategic partnerships, secured funding, and driven commercialization initiatives. Previously, he held senior leadership roles at Monash University’s Australian Regenerative Medicine […]